452 related articles for article (PubMed ID: 20161710)
1. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE
PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic antibody targeting of individual Notch receptors.
Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW
Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC
Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186
[TBL] [Abstract][Full Text] [Related]
4. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
5. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.
Sharma A; Gadkari RA; Ramakanth SV; Padmanabhan K; Madhumathi DS; Devi L; Appaji L; Aster JC; Rangarajan A; Dighe RR
Sci Rep; 2015 Jun; 5():11012. PubMed ID: 26046801
[TBL] [Abstract][Full Text] [Related]
6. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
[TBL] [Abstract][Full Text] [Related]
7. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2.
Gordon WR; Vardar-Ulu D; L'Heureux S; Ashworth T; Malecki MJ; Sanchez-Irizarry C; McArthur DG; Histen G; Mitchell JL; Aster JC; Blacklow SC
PLoS One; 2009 Aug; 4(8):e6613. PubMed ID: 19701457
[TBL] [Abstract][Full Text] [Related]
8. Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells.
Falk R; Falk A; Dyson MR; Melidoni AN; Parthiban K; Young JL; Roake W; McCafferty J
Methods; 2012 Sep; 58(1):69-78. PubMed ID: 22842086
[TBL] [Abstract][Full Text] [Related]
9. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
10. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
[TBL] [Abstract][Full Text] [Related]
11. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
12. The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities.
Sánchez-Solana B; Nueda ML; Ruvira MD; Ruiz-Hidalgo MJ; Monsalve EM; Rivero S; García-Ramírez JJ; Díaz-Guerra MJ; Baladrón V; Laborda J
Biochim Biophys Acta; 2011 Jun; 1813(6):1153-64. PubMed ID: 21419176
[TBL] [Abstract][Full Text] [Related]
13. Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1.
Berquam-Vrieze KE; Swing DA; Tessarollo L; Dupuy AJ
Genesis; 2012 Feb; 50(2):112-8. PubMed ID: 21898766
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
[TBL] [Abstract][Full Text] [Related]
15. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.
Mullendore ME; Koorstra JB; Li YM; Offerhaus GJ; Fan X; Henderson CM; Matsui W; Eberhart CG; Maitra A; Feldmann G
Clin Cancer Res; 2009 Apr; 15(7):2291-301. PubMed ID: 19258443
[TBL] [Abstract][Full Text] [Related]
16. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against the extracellular domain of human Notch1 receptor reveal the critical role of epidermal-growth-factor-like repeats 25-26 in ligand binding and receptor activation.
Sharma A; Rangarajan A; Dighe RR
Biochem J; 2013 Jan; 449(2):519-30. PubMed ID: 23072667
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
Volanakis EJ; Boothby MR; Sherr CJ
Exp Hematol; 2013 Apr; 41(4):377-86. PubMed ID: 23178376
[TBL] [Abstract][Full Text] [Related]
19. Insights into Notch3 activation and inhibition mediated by antibodies directed against its negative regulatory region.
Tiyanont K; Wales TE; Siebel CW; Engen JR; Blacklow SC
J Mol Biol; 2013 Sep; 425(17):3192-204. PubMed ID: 23747483
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.
Whiteman P; de Madrid BH; Taylor P; Li D; Heslop R; Viticheep N; Tan JZ; Shimizu H; Callaghan J; Masiero M; Li JL; Banham AH; Harris AL; Lea SM; Redfield C; Baron M; Handford PA
J Biol Chem; 2013 Mar; 288(10):7305-12. PubMed ID: 23339193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
